OSI Systems, Inc.

In exclusive interviews, Anne Whitaker, CEO of Aerami Therapeutics, who is passionate about mentoring and is active in promoting higher education in STEM sectors, and Filippo Petti, CEO of Celyad SA

Ten years is a long time and pulling out the events of true significance for the pharma industry in Japan over the past decade appears a tough challenge. But a look back at the major defining developm

10 years is a long time and pulling out the events of true significance for the pharma industry in Japan over the past decade appears a tough challenge. But a look back at the major defining developme

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Genentech Looks At Oncology